These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 9890234)
1. An audit of oestrogen implant hormone replacement therapy. Templeman C; Quinn D; Hansen R; Moreton T; Baber R Aust N Z J Obstet Gynaecol; 1998 Nov; 38(4):455-60. PubMed ID: 9890234 [TBL] [Abstract][Full Text] [Related]
2. An audit of oestradiol levels and implant frequency in women undergoing subcutaneous implant therapy. Buckler HM; Kalsi PK; Cantrill JA; Anderson DC Clin Endocrinol (Oxf); 1995 May; 42(5):445-50. PubMed ID: 7621560 [TBL] [Abstract][Full Text] [Related]
4. 25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy? Owen EJ; Siddle NC; McGarrigle HT; Pugh MA Br J Obstet Gynaecol; 1992 Aug; 99(8):671-5. PubMed ID: 1327094 [TBL] [Abstract][Full Text] [Related]
5. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women. Wide L; Naessén T; Phillips DJ Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633 [TBL] [Abstract][Full Text] [Related]
6. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy. Panay N; Versi E; Savvas M BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434 [TBL] [Abstract][Full Text] [Related]
7. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants. Thom MH; Collins WP; Studd JW Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745 [TBL] [Abstract][Full Text] [Related]
8. Circulating dehydroepiandrosterone-sulphate decreases even with a slight change in oestradiol. Matsui S; Yasui T; Kasai K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M J Obstet Gynaecol; 2018 Feb; 38(2):231-235. PubMed ID: 28903616 [TBL] [Abstract][Full Text] [Related]
10. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens. Savvas M; Studd JW; Norman S; Leather AT; Garnett TJ; Fogelman I Br J Obstet Gynaecol; 1992 Sep; 99(9):757-60. PubMed ID: 1420016 [TBL] [Abstract][Full Text] [Related]
11. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial. Birnbaum W; Marshall L; Werner R; Kulle A; Holterhus PM; Rall K; Köhler B; Richter-Unruh A; Hartmann MF; Wudy SA; Auer MK; Lux A; Kropf S; Hiort O Lancet Diabetes Endocrinol; 2018 Oct; 6(10):771-780. PubMed ID: 30075954 [TBL] [Abstract][Full Text] [Related]
12. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants. Naessén T; Persson I; Thor L; Mallmin H; Ljunghall S; Bergström R Br J Obstet Gynaecol; 1993 May; 100(5):454-9. PubMed ID: 8518246 [TBL] [Abstract][Full Text] [Related]
13. Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants. File SE; Heard JE; Rymer J Psychopharmacology (Berl); 2002 Apr; 161(1):107-12. PubMed ID: 11967638 [TBL] [Abstract][Full Text] [Related]
14. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women. Wide L; Naessén T; Eriksson K; Rune C Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177 [TBL] [Abstract][Full Text] [Related]
15. Clinical audit of estradiol implant therapy: Long duration of action and implications in non-hysterectomised women. Wheatley S; Bell RJ; Stuckey BG; Robinson PJ; Davis SR Maturitas; 2016 Dec; 94():84-86. PubMed ID: 27823750 [TBL] [Abstract][Full Text] [Related]
16. Long-term hormone implant therapy--effects on lipoproteins and steroid levels in post-menopausal women. Fletcher CD; Farish E; Hart DM; Barlow DH; Gray CE; Conaghan CJ Acta Endocrinol (Copenh); 1986 Mar; 111(3):419-23. PubMed ID: 3962567 [TBL] [Abstract][Full Text] [Related]
17. Are high levels of oestradiol after implants associated with features of dependence? O'Leary A; Bowen-Simpkins P; Tejura H; Rajesh U Br J Obstet Gynaecol; 1999 Sep; 106(9):960-3. PubMed ID: 10492109 [TBL] [Abstract][Full Text] [Related]
18. Oestradiol implants for gender-affirming hormone therapy: an observational study of serum oestradiol levels and consumer survey. Mesure J; Afrin S; Fitzgerald S; Luu J; Gibberd A; Leigh L; Wynne K Sex Health; 2023 Dec; 20(6):550-557. PubMed ID: 37845025 [TBL] [Abstract][Full Text] [Related]
19. The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women. Farish E; Fletcher CD; Hart DM; Azzawi FA; Abdalla HI; Gray CE Acta Endocrinol (Copenh); 1984 May; 106(1):116-20. PubMed ID: 6730851 [TBL] [Abstract][Full Text] [Related]
20. Treatment of menopausal oestrogen deficiency symptoms in hysterectomised women by means of 17beta-oestradiol pellet implants. Staland B Acta Obstet Gynecol Scand; 1978; 57(3):281-5. PubMed ID: 665176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]